Page last updated: 2024-10-26

donepezil and Hakim Syndrome

donepezil has been researched along with Hakim Syndrome in 1 studies

Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yusim, A1
Anbarasan, D1
Bernstein, C1
Boksay, I1
Dulchin, M1
Lindenmayer, JP1
Saavedra-Velez, C1
Shapiro, M1
Sadock, B1

Reviews

1 review available for donepezil and Hakim Syndrome

ArticleYear
Normal pressure hydrocephalus presenting as Othello syndrome: case presentation and review of the literature.
    The American journal of psychiatry, 2008, Volume: 165, Issue:9

    Topics: Aged; Antipsychotic Agents; Cerebral Ventricles; Cholinesterase Inhibitors; Cognition Disorders; Cor

2008